Suchergebnisse - "Pinato, David J"

PubPharm (6)

1

Host immune-inflammatory markers to unravel the heterogeneous outcome and assessment of patients with PD-L1 ≥50% metastatic non-small cell lung cancer and poor performance status receiving first-line immunotherapy

enthalten in: Thoracic cancer | 2022

von Banna, G. | Tiseo, M. | Cortinovis, D. | +31

2

Exploration of Novel Prognostic Markers in Grade 3 Neuroendocrine Neoplasia

enthalten in: Cancers | 2021

von Abdelmalak, R. | Lythgoe, M. | Evans, J. | +5

3

Clinical outcomes of patients with corticosteroid refractory immune checkpoint inhibitor-induced enterocolitis treated with infliximab

enthalten in: Journal for immunotherapy of cancer | 2021

von Alexander, J. | Ibraheim, H. | Sheth, B. | +20

4

Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection : the OnCovid Inflammatory Score

enthalten in: Journal for immunotherapy of cancer | 2021

von Dettorre, G. | Dolly, S. | Loizidou, A. | +59

ErratumIn: J Immunother Cancer. 2021 Jun;9(6):. - PMID 34135105

5

The systemic inflammatory response as a source of biomarkers and therapeutic targets in hepatocellular carcinoma

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2019

von Sanghera, C. | Teh, J. | Pinato, D.

6

Integration of the cancer-related inflammatory response as a stratifying biomarker of survival in hepatocellular carcinoma treated with sorafenib

enthalten in: Oncotarget | 2017

von Howell, J. | Pinato, D. | Ramaswami, R. | +11

1
[1]